Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide associatio...
Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Pharmacotherapeutic options are limited for hepatocellular carcinoma (HCC). Recently, we identified the anti-tumor ligand MHC class I polypeptide-related sequence A (
MICA
) gene as a susceptibility gene for hepatitis C virus-induced HCC in a genome-wide association study (GWAS). To prove the concept of HCC immunotherapy based on the results...
Alternative Titles
Full title
Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5133582
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5133582
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/srep38407
